Capital Analysts LLC’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BBA
DGM
Capital Analysts LLC's RVMD Position: Q3 2026 in Review
Capital Analysts LLC opened a new position in Revolution Medicines (RVMD) in Q3 2026: 4 shares worth $821. The stake represents ﹤0.01% of the portfolio and ranks #1566 among its holdings.
756 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- Capital Analysts LLC held 4 shares of Revolution Medicines worth $821 as of Q3 2026.
- Revolution Medicines was a new Capital Analysts LLC position in Q3 2026.
- Revolution Medicines made up ﹤0.01% of Capital Analysts LLC's portfolio in Q3 2026, its #1566 holding.
- 756 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on Capital Analysts LLC's 13F filing for Q3 2026, filed 13 Nov 2026.